BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23920272)

  • 1. α-Synuclein is a pathological link and therapeutic target for Parkinson's disease and traumatic brain injury.
    Shahaduzzaman M; Acosta S; Bickford PC; Borlongan CV
    Med Hypotheses; 2013 Oct; 81(4):675-80. PubMed ID: 23920272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mitochondrial dysfunction and oxidative damages in the molecular pathology of Parkinson's disease].
    Shadrina MI; Slominskiĭ PA
    Mol Biol (Mosk); 2008; 42(5):809-19. PubMed ID: 18988530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease.
    Thomas B; Beal MF
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Parkinson's disease-related genes act in mitochondrial homeostasis.
    Sai Y; Zou Z; Peng K; Dong Z
    Neurosci Biobehav Rev; 2012 Oct; 36(9):2034-43. PubMed ID: 22771336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
    Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
    Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of recent genetic findings in Parkinson's disease.
    Klein C; Lohmann-Hedrich K
    Curr Opin Neurol; 2007 Aug; 20(4):453-64. PubMed ID: 17620882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging pathways in genetic Parkinson's disease.
    Lewis PA
    FEBS J; 2008 Dec; 275(23):5747. PubMed ID: 19021751
    [No Abstract]   [Full Text] [Related]  

  • 9. Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease.
    Venderova K; Kabbach G; Abdel-Messih E; Zhang Y; Parks RJ; Imai Y; Gehrke S; Ngsee J; Lavoie MJ; Slack RS; Rao Y; Zhang Z; Lu B; Haque ME; Park DS
    Hum Mol Genet; 2009 Nov; 18(22):4390-404. PubMed ID: 19692353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease.
    Acosta SA; Tajiri N; de la Pena I; Bastawrous M; Sanberg PR; Kaneko Y; Borlongan CV
    J Cell Physiol; 2015 May; 230(5):1024-32. PubMed ID: 25251017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of oxidative stress in Parkinson's disease.
    Dias V; Junn E; Mouradian MM
    J Parkinsons Dis; 2013; 3(4):461-91. PubMed ID: 24252804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis in Parkinson's disease: is p53 the missing link between genetic and sporadic Parkinsonism?
    Alves da Costa C; Checler F
    Cell Signal; 2011 Jun; 23(6):963-8. PubMed ID: 20969953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic dysfunction in Parkinson's disease.
    Picconi B; Piccoli G; Calabresi P
    Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of Parkinson's disease: implications from familial Parkinson's disease].
    Iwatsubo T; Ito G; Takatori S; Hannno Y; Kuwahara T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):899-901. PubMed ID: 16447757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From genes to proteins in mendelian Parkinson's disease: an overview.
    Pirkevi C; Lesage S; Brice A; Başak AN
    Anat Rec (Hoboken); 2009 Dec; 292(12):1893-901. PubMed ID: 19943343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of Parkinson's disease.
    Bonifati V
    Minerva Med; 2005 Jun; 96(3):175-86. PubMed ID: 16175160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical genetics of Parkinson's disease and related disorders.
    Wider C; Wszolek ZK
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium signaling in Parkinson's disease.
    Calì T; Ottolini D; Brini M
    Cell Tissue Res; 2014 Aug; 357(2):439-54. PubMed ID: 24781149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.